119 related articles for article (PubMed ID: 10505113)
1. Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation.
Schagen FH; Moor AC; Cheong SC; Cramer SJ; van Ormondt H; van der Eb AJ; Dubbelman TM; Hoeben RC
Gene Ther; 1999 May; 6(5):873-81. PubMed ID: 10505113
[TBL] [Abstract][Full Text] [Related]
2. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
3. Localized adenovirus gene delivery using antiviral IgG complexation.
Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
[TBL] [Abstract][Full Text] [Related]
4. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
[TBL] [Abstract][Full Text] [Related]
5. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins.
Wang D; Bu F; Xu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
8. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
Hoffmann D; Jogler C; Wildner O
J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer by adenovirus-mimetic peptides in the presence of a cationic lipid and/or adenovirus. Analysis of the contribution of the viral and nonviral components.
Moritz S; Colin M; Keller M; Klonjkowski B; Capeau J; Coutelle C; Chroboczek J; Brahimi-Horn MC
Arch Virol; 2003 Jan; 148(1):1-18. PubMed ID: 12536292
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of adenoviral vectors by flow cytometry.
Weaver LS; Kadan MJ
Methods; 2000 Jul; 21(3):297-312. PubMed ID: 10873484
[TBL] [Abstract][Full Text] [Related]
11. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.
Stachelek SJ; Song C; Alferiev I; Defelice S; Cui X; Connolly JM; Bianco RW; Levy RJ
Gene Ther; 2004 Jan; 11(1):15-24. PubMed ID: 14681693
[TBL] [Abstract][Full Text] [Related]
12. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.
Kim J; Cho JY; Kim JH; Jung KC; Yun CO
Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
16. Cell-selective viral gene delivery vectors for the vasculature.
Baker AH; Kritz A; Work LM; Nicklin SA
Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
[TBL] [Abstract][Full Text] [Related]
17. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
18. Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy.
Høgset A; Engesaeter BO; Prasmickaite L; Berg K; Fodstad O; Maelandsmo GM
Cancer Gene Ther; 2002 Apr; 9(4):365-71. PubMed ID: 11960287
[TBL] [Abstract][Full Text] [Related]
19. Correction of argininosuccinate synthetase (AS) deficiency in a murine model of citrullinemia with recombinant adenovirus carrying human AS cDNA.
Ye X; Whiteman B; Jerebtsova M; Batshaw ML
Gene Ther; 2000 Oct; 7(20):1777-82. PubMed ID: 11083500
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]